Suppr超能文献

双重PI3K/mToR抑制剂奥米帕利司/GSK2126458抑制神经皮肤黑素沉着症致癌转化细胞的克隆生长。

The Dual PI3K/mToR Inhibitor Omipalisib/GSK2126458 Inhibits Clonogenic Growth in Oncogenically-transformed Cells from Neurocutaneous Melanocytosis.

作者信息

Basu Dipanjan, Salgado Cláudia M, Bauer Bruce, Khakoo Yasmin, Patel Janki R, Hoehl Ryan M, Bertolini Dominique M, Zabec Joie, Brzozowski Morgan R, Reyes-Múgica Miguel

机构信息

Department of Pathology, Children's Hospital of Pittsburgh, Pittsburgh, PA, U.S.A

Department of Pathology, Children's Hospital of Pittsburgh, Pittsburgh, PA, U.S.A.

出版信息

Cancer Genomics Proteomics. 2018 Jul-Aug;15(4):239-248. doi: 10.21873/cgp.20082.

Abstract

BACKGROUND

Omipalisib has been found to affect the viability of cancer cells. However, its effect on clonogenicity - a feature of cancer stem cells, is not clear. Cells isolated from neurocutaneous melanocytosis (NCM) patients' lesions grow clonogenically. The aim of this study was to investigate the effect of omipalisib treatment on clonogenic growth of NCM cells in vitro.

MATERIALS AND METHODS

Clonogenic growth efficiency was evaluated by colony formation assays with or without specific growth factors. Activation of MEK and Akt was determined by immunoblots. Colony formation and cell viability were assessed upon pharmacological inhibition of MEK, Akt and mToR.

RESULTS

Clonogenicity appeared to depend on bFGF and IGF1signaling through ERK and Akt. Omipalisib treatment prevented colony formation and induced autophagic cell death.

CONCLUSION

Signaling through Akt is important for survival of clonogenic cells in NCM, and omipalisib treatment as a monotherapy or in combination with MEK162 could be an effective therapeutic strategy to inhibit clonogenic growth.

摘要

背景

已发现奥米帕利西布会影响癌细胞的活力。然而,其对克隆形成能力(癌症干细胞的一个特征)的影响尚不清楚。从神经皮肤黑素沉着症(NCM)患者病变部位分离出的细胞具有克隆生长能力。本研究的目的是调查奥米帕利西布处理对体外培养的NCM细胞克隆生长的影响。

材料与方法

通过有无特定生长因子的集落形成试验评估克隆生长效率。通过免疫印迹法测定MEK和Akt的激活情况。在对MEK、Akt和mToR进行药理抑制后评估集落形成和细胞活力。

结果

克隆形成能力似乎依赖于通过ERK和Akt的bFGF和IGF1信号传导。奥米帕利西布处理可阻止集落形成并诱导自噬性细胞死亡。

结论

通过Akt的信号传导对NCM中克隆形成细胞的存活很重要,奥米帕利西布单药治疗或与MEK162联合使用可能是抑制克隆生长的有效治疗策略。

相似文献

3
Neurocutaneous melanocytosis (melanosis).
Childs Nerv Syst. 2020 Oct;36(10):2571-2596. doi: 10.1007/s00381-020-04770-9. Epub 2020 Oct 13.
10
Synergistic anti-tumor effect of 17AAG with the PI3K/mTOR inhibitor NVP-BEZ235 on human melanoma.
Cancer Lett. 2017 Oct 10;406:1-11. doi: 10.1016/j.canlet.2017.07.021. Epub 2017 Aug 1.

引用本文的文献

1
Congenital melanocytic neoplasms: clinical, histopathological and recent molecular developments.
Virchows Arch. 2025 Jan;486(1):165-176. doi: 10.1007/s00428-024-04011-3. Epub 2025 Jan 15.
2
Three generations of mTOR kinase inhibitors in the activation of the apoptosis process in melanoma cells.
J Cell Commun Signal. 2023 Sep;17(3):975-989. doi: 10.1007/s12079-023-00748-9. Epub 2023 Apr 25.
3
Metabolic Interventions in Tumor Immunity: Focus on Dual Pathway Inhibitors.
Cancers (Basel). 2023 Mar 29;15(7):2043. doi: 10.3390/cancers15072043.
5
Recent Advances in Dual PI3K/mTOR Inhibitors for Tumour Treatment.
Front Pharmacol. 2022 May 9;13:875372. doi: 10.3389/fphar.2022.875372. eCollection 2022.
8
Neurocutaneous melanocytosis (melanosis).
Childs Nerv Syst. 2020 Oct;36(10):2571-2596. doi: 10.1007/s00381-020-04770-9. Epub 2020 Oct 13.

本文引用的文献

1
Functional screening of FGFR4-driven tumorigenesis identifies PI3K/mTOR inhibition as a therapeutic strategy in rhabdomyosarcoma.
Oncogene. 2018 May;37(20):2630-2644. doi: 10.1038/s41388-017-0122-y. Epub 2018 Feb 28.
2
New Drug Combination Strategies in Melanoma: Current Status and Future Directions.
Anticancer Res. 2017 Nov;37(11):5941-5953. doi: 10.21873/anticanres.12041.
3
Targeting of the MAPK and AKT pathways in conjunctival melanoma shows potential synergy.
Oncotarget. 2016 Jul 22;8(35):58021-58036. doi: 10.18632/oncotarget.10770. eCollection 2017 Aug 29.
4
The HSP90 inhibitor, NVP-AUY922, attenuates intrinsic PI3K inhibitor resistance in KRAS-mutant non-small cell lung cancer.
Cancer Lett. 2017 Oct 10;406:47-53. doi: 10.1016/j.canlet.2017.07.028. Epub 2017 Aug 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验